Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an announcement.
Integral Diagnostics Limited announced the release date for its FY25 Half Year results, scheduled for 26 February 2025, followed by a group investor conference call. This announcement underscores the company’s commitment to transparency and engagement with its investors, potentially impacting its market positioning and stakeholder relations.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing some of Australasia’s top radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model to ensure quality patient care, service, and access.
YTD Price Performance: 1.72%
Average Trading Volume: 886,960
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$1.1B
Find detailed analytics on IDX stock on TipRanks’ Stock Analysis page.
